Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea hypopnea syndrome: effect of continuous positive airway pressure treatment

Thumbnail
View/Open
Issue date
2014
Author
Barceló Bennasar, Antònia
Piérola, Javier
Esquinas López, Cristina
Peña, Mónica de la
Arqué, Meritxell
Alonso-Fernández, Alberto
Bauçà, Josep Miquel
Robles, Juan
Barceló, Bernardino
Barbé Illa, Ferran
Suggested citation
Barceló Bennasar, Antònia; Piérola, Javier; Esquinas López, Cristina; Peña, Mónica de la; Arqué, Meritxell; Alonso-Fernández, Alberto; ... Barbé Illa, Ferran. (2014) . Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea hypopnea syndrome: effect of continuous positive airway pressure treatment. Plos One, 2014, vol. 9, núm. 1, e84362. https://doi.org/10.1371/journal.pone.0084362.
Impact

Google Scholar logo  Google Scholar
Share
Export to Mendeley
Metadata
Show full item record
Abstract
Methods: We studied 66 patients with OSAHS (33 with MS and 33 without MS) and 35 controls. The occurrence of the MS was analyzed according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) clinical criteria. Measurements of plasma renin activity (PRA), aldosterone,
aldosterone:PRA ratio, creatinine, glucose, triglycerides, cholesterol and HDL cholesterol were obtained at baseline and after CPAP treatment. Results: Aldosterone levels were associated with the severity of OSAHS and higher than controls (p = 0.046). Significant differences in aldosterone levels were detected between OSAHS patients with and without MS (p = 0.041). A significant reduction was observed in the aldosterone levels in patients under CPAP treatment (p = 0.012). Conclusion: This study shows that aldosterone levels are elevated in OSAHS in comparison to controls, and that CPAP therapy reduces aldosterone levels. It also shows that aldosterone levels are associated with the presence of metabolic syndrome, suggesting that aldosterone excess might predispose or aggravate the metabolic and cardiovascular complications of OSAHS. Trial registration: The study is not a randomized controlled trial and was not registered.
URI
http://hdl.handle.net/10459.1/55720
DOI
https://doi.org/10.1371/journal.pone.0084362
Is part of
Plos One, 2014, vol. 9, núm. 1, e84362
Collections

The following license files are associated with this item:

cc-by, (c) Barceló et al., 2014
Except where otherwise noted, this item's license is described as cc-by, (c) Barceló et al., 2014